Nanogen, Epoch, German Resource Center for Genome Research, Children s Hospital of Boston, Luminex, Genospectra, EPO, Applera, Nanomix, Ocimum, Genome Explorations, Bioforce | GenomeWeb

Nanogen, Epoch Postpone Merger Vote for One Week; Quorum Not Reached

Nanogen and Epoch Biosciences adjourned their special shareholder meetings last Wednesday and postponed until Dec. 15 a vote on their merger after an insufficient number of stockholders were present or represented by proxy at the Nanogen meeting.

Epoch, which also postponed the vote until Dec. 15, had reached a quorum at its special shareholder meeting and had sufficient votes to approve the merger.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.